13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001792206
Total reported value
$362.2M
$362.2M
6 檔
31.7%
As reported in its official Q4 2024 Form 13F filing, Foresite Capital Management V, LLC's tracked investment portfolio stood at $362.2M with 6 total positions.
In Q4 2024, Foresite Capital Management V, LLC displayed an active expansion posture, initiating 1 new positions and adding to 1 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALMS | Alumis Inc | Stock-Other | 37.79% | -2.13% | +3.48% | |
| 2 | HIMS | Hims & Hers Health Inc | Stock-Healthcare | 18.91% | +1.42% | -46.58% | |
| 3 | CGON | Cg Oncology Inc | Stock-Other | 16.53% | -3.91% | — | |
| 4 | IRON | Disc Medicine Inc | Stock-Other | 15.78% | -1.28% | — | |
| 5 | CGEM | Cullinan Therapeutics Inc | Stock-Other | 6.67% | — | — | |
| 6 | LYEL | Lyell Immunopharma, Inc. | Stock-Other | 4.33% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | IRON | Disc Medicine Inc | +5.6% | — | Unchanged |
| 2 | LYEL | Lyell Immunopharma, Inc. | +4.3% | NEW | New buy |
| 3 | CGEM | Cullinan Therapeutics Inc | -1% | — | Unchanged |
| 4 | CGON | Cg Oncology Inc | -1.6% | — | Unchanged |
| 5 | HIMS | Hims & Hers Health Inc | -3.6% | -46.58% | Trim |
| 6 | ALMS | Alumis Inc | -3.7% | +3.48% | Add |
According to official SEC Form 13F filings, Foresite Capital Management V, LLC reported a total U.S. public equity portfolio value of $362.2M across 6 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ALMS, HIMS, CGON) accounted for 31.7% of total reported equity market value during Q4 2024.
Top New Position Initiated
LYEL
市值: $5.2M
Top Position Liquidated / Trimmed
HIMS
前期市值: $32.4M
During Q4 2024, Foresite Capital Management V, LLC's top holdings by market value included ALMS (37.8%)、HIMS (18.9%)、CGON (16.5%). The largest single position, ALMS, represented 37.8% of total portfolio value.
In Q4 2024, Foresite Capital Management V, LLC made 3 total portfolio adjustments, initiating 1 new buys, adding to 1 positions, trimming 1 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.